Copyright Reports & Markets. All rights reserved.

Global Pharmacovigilance Market Size, Status and Forecast 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global Pharmacovigilance Market Size Growth Rate by Type (2014-2025)
      • 1.4.2 Chemotherapy
      • 1.4.3 Contract Outsourcing
    • 1.5 Market by Application
      • 1.5.1 Global Pharmacovigilance Market Share by Application (2014-2025)
      • 1.5.2 Pharma and Biotech Companies
      • 1.5.3 Contract Research Organizations (CROs)
      • 1.5.4 Business Process Outsourcing (BPO) Firms
      • 1.5.5 Other Pharmacovigilance Service Providers
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 Pharmacovigilance Market Size
    • 2.2 Pharmacovigilance Growth Trends by Regions
      • 2.2.1 Pharmacovigilance Market Size by Regions (2014-2025)
      • 2.2.2 Pharmacovigilance Market Share by Regions (2014-2019)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Opportunities

    3 Market Share by Key Players

    • 3.1 Pharmacovigilance Market Size by Manufacturers
      • 3.1.1 Global Pharmacovigilance Revenue by Manufacturers (2014-2019)
      • 3.1.2 Global Pharmacovigilance Revenue Market Share by Manufacturers (2014-2019)
      • 3.1.3 Global Pharmacovigilance Market Concentration Ratio (CR5 and HHI)
    • 3.2 Pharmacovigilance Key Players Head office and Area Served
    • 3.3 Key Players Pharmacovigilance Product/Solution/Service
    • 3.4 Date of Enter into Pharmacovigilance Market
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type and Application

    • 4.1 Global Pharmacovigilance Market Size by Type (2014-2019)
    • 4.2 Global Pharmacovigilance Market Size by Application (2014-2019)

    5 United States

    • 5.1 United States Pharmacovigilance Market Size (2014-2019)
    • 5.2 Pharmacovigilance Key Players in United States
    • 5.3 United States Pharmacovigilance Market Size by Type
    • 5.4 United States Pharmacovigilance Market Size by Application

    6 Europe

    • 6.1 Europe Pharmacovigilance Market Size (2014-2019)
    • 6.2 Pharmacovigilance Key Players in Europe
    • 6.3 Europe Pharmacovigilance Market Size by Type
    • 6.4 Europe Pharmacovigilance Market Size by Application

    7 China

    • 7.1 China Pharmacovigilance Market Size (2014-2019)
    • 7.2 Pharmacovigilance Key Players in China
    • 7.3 China Pharmacovigilance Market Size by Type
    • 7.4 China Pharmacovigilance Market Size by Application

    8 Japan

    • 8.1 Japan Pharmacovigilance Market Size (2014-2019)
    • 8.2 Pharmacovigilance Key Players in Japan
    • 8.3 Japan Pharmacovigilance Market Size by Type
    • 8.4 Japan Pharmacovigilance Market Size by Application

    9 Southeast Asia

    • 9.1 Southeast Asia Pharmacovigilance Market Size (2014-2019)
    • 9.2 Pharmacovigilance Key Players in Southeast Asia
    • 9.3 Southeast Asia Pharmacovigilance Market Size by Type
    • 9.4 Southeast Asia Pharmacovigilance Market Size by Application

    10 India

    • 10.1 India Pharmacovigilance Market Size (2014-2019)
    • 10.2 Pharmacovigilance Key Players in India
    • 10.3 India Pharmacovigilance Market Size by Type
    • 10.4 India Pharmacovigilance Market Size by Application

    11 Central & South America

    • 11.1 Central & South America Pharmacovigilance Market Size (2014-2019)
    • 11.2 Pharmacovigilance Key Players in Central & South America
    • 11.3 Central & South America Pharmacovigilance Market Size by Type
    • 11.4 Central & South America Pharmacovigilance Market Size by Application

    12 International Players Profiles

    • 12.1 Eli Lilly and Company
      • 12.1.1 Eli Lilly and Company Company Details
      • 12.1.2 Company Description and Business Overview
      • 12.1.3 Pharmacovigilance Introduction
      • 12.1.4 Eli Lilly and Company Revenue in Pharmacovigilance Business (2014-2019)
      • 12.1.5 Eli Lilly and Company Recent Development
    • 12.2 ICON plc
      • 12.2.1 ICON plc Company Details
      • 12.2.2 Company Description and Business Overview
      • 12.2.3 Pharmacovigilance Introduction
      • 12.2.4 ICON plc Revenue in Pharmacovigilance Business (2014-2019)
      • 12.2.5 ICON plc Recent Development
    • 12.3 Elsevier
      • 12.3.1 Elsevier Company Details
      • 12.3.2 Company Description and Business Overview
      • 12.3.3 Pharmacovigilance Introduction
      • 12.3.4 Elsevier Revenue in Pharmacovigilance Business (2014-2019)
      • 12.3.5 Elsevier Recent Development
    • 12.4 Chiltern
      • 12.4.1 Chiltern Company Details
      • 12.4.2 Company Description and Business Overview
      • 12.4.3 Pharmacovigilance Introduction
      • 12.4.4 Chiltern Revenue in Pharmacovigilance Business (2014-2019)
      • 12.4.5 Chiltern Recent Development
    • 12.5 Atlantic Research Group
      • 12.5.1 Atlantic Research Group Company Details
      • 12.5.2 Company Description and Business Overview
      • 12.5.3 Pharmacovigilance Introduction
      • 12.5.4 Atlantic Research Group Revenue in Pharmacovigilance Business (2014-2019)
      • 12.5.5 Atlantic Research Group Recent Development
    • 12.6 Mapi Group
      • 12.6.1 Mapi Group Company Details
      • 12.6.2 Company Description and Business Overview
      • 12.6.3 Pharmacovigilance Introduction
      • 12.6.4 Mapi Group Revenue in Pharmacovigilance Business (2014-2019)
      • 12.6.5 Mapi Group Recent Development
    • 12.7 Accenture Plc.
      • 12.7.1 Accenture Plc. Company Details
      • 12.7.2 Company Description and Business Overview
      • 12.7.3 Pharmacovigilance Introduction
      • 12.7.4 Accenture Plc. Revenue in Pharmacovigilance Business (2014-2019)
      • 12.7.5 Accenture Plc. Recent Development
    • 12.8 Clinquest Group B.V.
      • 12.8.1 Clinquest Group B.V. Company Details
      • 12.8.2 Company Description and Business Overview
      • 12.8.3 Pharmacovigilance Introduction
      • 12.8.4 Clinquest Group B.V. Revenue in Pharmacovigilance Business (2014-2019)
      • 12.8.5 Clinquest Group B.V. Recent Development
    • 12.9 GSK
      • 12.9.1 GSK Company Details
      • 12.9.2 Company Description and Business Overview
      • 12.9.3 Pharmacovigilance Introduction
      • 12.9.4 GSK Revenue in Pharmacovigilance Business (2014-2019)
      • 12.9.5 GSK Recent Development
    • 12.10 PRA Health Sciences, Inc.
      • 12.10.1 PRA Health Sciences, Inc. Company Details
      • 12.10.2 Company Description and Business Overview
      • 12.10.3 Pharmacovigilance Introduction
      • 12.10.4 PRA Health Sciences, Inc. Revenue in Pharmacovigilance Business (2014-2019)
      • 12.10.5 PRA Health Sciences, Inc. Recent Development

    13 Market Forecast 2019-2025

    • 13.1 Market Size Forecast by Regions
    • 13.2 United States
    • 13.3 Europe
    • 13.4 China
    • 13.5 Japan
    • 13.6 Southeast Asia
    • 13.7 India
    • 13.8 Central & South America
    • 13.9 Market Size Forecast by Product (2019-2025)
    • 13.10 Market Size Forecast by Application (2019-2025)

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 12.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Disclaimer

      In 2018, the global Pharmacovigilance market size was million US$ and it is expected to reach million US$ by the end of 2025, with a CAGR of during 2019-2025.

      This report focuses on the global Pharmacovigilance status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Pharmacovigilance development in United States, Europe and China.

      The key players covered in this study
      Eli Lilly and Company
      ICON plc
      Elsevier
      Chiltern
      Atlantic Research Group
      Mapi Group
      Accenture Plc.
      Clinquest Group B.V.
      GSK
      PRA Health Sciences, Inc.

      Market segment by Type, the product can be split into
      Chemotherapy
      Contract Outsourcing

      Market segment by Application, split into
      Pharma and Biotech Companies
      Contract Research Organizations (CROs)
      Business Process Outsourcing (BPO) Firms
      Other Pharmacovigilance Service Providers

      Market segment by Regions/Countries, this report covers
      United States
      Europe
      China
      Japan
      Southeast Asia
      India
      Central & South America

      The study objectives of this report are:
      To analyze global Pharmacovigilance status, future forecast, growth opportunity, key market and key players.
      To present the Pharmacovigilance development in United States, Europe and China.
      To strategically profile the key players and comprehensively analyze their development plan and strategies.
      To define, describe and forecast the market by product type, market and key regions.

      In this study, the years considered to estimate the market size of Pharmacovigilance are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025
      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now